We are live on ! Find out more
EIP

Easterly Investment Partners Portfolio holdings

AUM $1.97B
1-Year Est. Return 25.87%
This Fund
S&P 500
This Quarter Est. Return
+5.14%
1 Year Est. Return
+25.87%
3 Year Est. Return
+57.65%
5 Year Est. Return
+62.99%
10 Year Est. Return
AUM
$1.13B
AUM Growth
-$6.47M
Cap. Flow
-$49.4M
Cap. Flow %
-4.37%
Top 10 Hldgs %
20.33%
Holding
211
New
19
Increased
62
Reduced
81
Closed
15

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$9.47M
2
INTC icon
Intel
INTC
+$7.91M
3
AMGN icon
Amgen
AMGN
+$7.16M
4
PPC icon
Pilgrim's Pride
PPC
+$6.76M
5
VRT icon
Vertiv
VRT
+$5.61M

Sector Composition

Rank Sector Weight
1 Financials 19.56%
2 Healthcare 16.57%
3 Technology 12.18%
4 Energy 10.79%
5 Industrials 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWN
101
DELISTED
Southwestern Energy Company
SWN
$2.46M 0.22%
410,092
-150,533
-27% -$776K
ABBV icon
102
AbbVie
ABBV
$435B
$2.46M 0.22%
18,244
+4,009
+28% +$588K
SAGE
103
DELISTED
Sage Therapeutics
SAGE
$2.4M 0.21%
51,121
-29,524
-37% -$1.47M
IP icon
104
International Paper
IP
$22B
$2.4M 0.21%
75,538
-2,998
-4% -$98.2K
FCX icon
105
Freeport-McMoran
FCX
$97.5B
$2.34M 0.21%
58,585
+3,873
+7% +$148K
MRO
106
DELISTED
Marathon Oil Corporation
MRO
$2.32M 0.21%
+100,698
New +$2.37M
NCLH icon
107
Norwegian Cruise Line
NCLH
$8.84B
$2.24M 0.2%
102,938
-13
-0% -$199
PNR icon
108
Pentair
PNR
$11B
$2.13M 0.19%
32,911
-818
-2% -$47.1K
SAGE
109
CALL
DELISTED
Sage Therapeutics
SAGE
$2.01M 0.18%
+42,800
New +$2.13M
BIIB icon
110
Biogen
BIIB
$30.7B
$1.96M 0.17%
6,889
XBI icon
111
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$1.92M 0.17%
23,062
+1,000
+5% +$83.6K
NTAP icon
112
NetApp
NTAP
$37.2B
$1.91M 0.17%
24,947
+7,252
+41% +$490K
BIV icon
113
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$1.9M 0.17%
25,305
-1,318
-5% -$100K
AMLP icon
114
Alerian MLP ETF
AMLP
$12.8B
$1.83M 0.16%
46,619
ACCO icon
115
Acco Brands
ACCO
$407M
$1.79M 0.16%
343,709
-239,950
-41% -$1.21M
MED icon
116
Medifast
MED
$141M
$1.79M 0.16%
19,378
+11,563
+148% +$1.03M
MOD icon
117
Modine Manufacturing
MOD
$10.4B
$1.77M 0.16%
53,594
-4,000
-7% -$99.8K
UL icon
118
Unilever
UL
$136B
$1.75M 0.15%
29,786
-214,139
-88% -$12.7M
VST icon
119
Vistra
VST
$47.4B
$1.71M 0.15%
65,333
-3,334
-5% -$81.5K
AGI icon
120
Alamos Gold
AGI
$13.9B
$1.66M 0.15%
139,046
+9,685
+7% +$123K
VUG icon
121
Vanguard Morningstar Growth ETF
VUG
$231B
$1.63M 0.14%
34,536
-48
-0.1% -$2.08K
AAPL icon
122
Apple
AAPL
$4.57T
$1.62M 0.14%
8,372
NOG icon
123
Northern Oil and Gas
NOG
$2.35B
$1.61M 0.14%
+46,791
New +$1.52M
FCF icon
124
First Commonwealth Financial
FCF
$2.17B
$1.54M 0.14%
121,822
+5,000
+4% +$63.1K
BTG icon
125
B2Gold
BTG
$6.64B
$1.54M 0.14%
430,862

Similar funds

Easterly Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Easterly Investment Partners held 211 positions worth $1.13B, down 0.57% from $1.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Easterly Investment Partners withdrew a net $49.4M in Q2 2023, closing 15 positions and reducing 81 holdings. Its most notable exit was Lennox International, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Easterly Investment Partners opened a new position in Kellanova worth $9.39M.

  • Easterly Investment Partners's largest Q2 2023 buy was Kellanova: 148,423 shares worth $9.39M.
  • Easterly Investment Partners added most to Amgen in Q2 2023, an estimated $7.16M increase.
  • Easterly Investment Partners's biggest Q2 2023 reduction was Super Micro Computer, cutting an estimated $22.6M.
  • Easterly Investment Partners fully exited Lennox International in Q2 2023, selling an estimated $18.1M.
  • Easterly Investment Partners's ten largest holdings make up 20% of its $1.13B portfolio in Q2 2023.
  • Easterly Investment Partners opened 19 new positions and closed 15 in Q2 2023.
  • Easterly Investment Partners's portfolio value fell 0.57% quarter-over-quarter to $1.13B.

Based on Easterly Investment Partners's 13F filing for Q2 2023, filed 13 Nov 2023.